Related Experiment Video

Updated: Jun 23, 2026

Murine Intrapulmonary Tracheal Transplantation: A Model for Investigating Obliterative Airway Disease After Lung Transplantation
06:15

Murine Intrapulmonary Tracheal Transplantation: A Model for Investigating Obliterative Airway Disease After Lung Transplantation

Published on: November 10, 2023

Central airways obstruction due to Aspergillus fumigatus after lung transplantation

Elizabeth Cerceo1, Robert M Kotloff, Denis Hadjiliadis

  • 1Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.

The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|May 7, 2009
PubMed

Insights

A new pulmonary complication caused by Aspergillus fumigatus was identified in lung transplant recipients. This condition involves airway obstruction and mucus plugs, but responds to antifungal and steroid treatments.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Transplantation Medicine

Background:

  • Immunocompromised patients, particularly lung transplant recipients, are susceptible to opportunistic infections.
  • Aspergillus fumigatus is a common fungal pathogen that can cause severe lung disease in vulnerable populations.

Observation:

  • Three bilateral lung transplant patients presented with a novel pulmonary manifestation of Aspergillus fumigatus.
  • This manifestation was characterized by a rapid decline in pulmonary function.
  • Bronchoscopy revealed large central airway obstruction due to thick, mucus-laden plugs heavily colonized by Aspergillus species.

Findings:

  • The patients exhibited atypical clinical features of Aspergillus infection.
  • All three patients demonstrated a positive response to therapeutic interventions.
  • Treatment regimens included corticosteroids, antifungal agents, or a combination of both.

Implications:

  • This case series highlights a previously undescribed pulmonary complication of Aspergillus fumigatus in lung transplant recipients.
  • Early recognition and appropriate treatment, including antifungals and steroids, are crucial for managing this condition.
  • Further research is warranted to understand the pathogenesis and optimize treatment strategies for this specific Aspergillus-related airway disease.

More Related Videos

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation07:28

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Published on: October 11, 2024

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...